Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2016 | 07-2016 | 04-2016 | 01-2016 | 10-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112 | 84 | 118 | 283 | 270 |
| Receivables | 121 | 108 | 55 | 94 | 85 |
| Inventories | 68 | 124 | 127 | 42 | 69 |
| TOTAL | $300 | $316 | $300 | $419 | $424 |
| Non-Current Assets | |||||
| PPE Net | 152 | 160 | 164 | 195 | 194 |
| TOTAL | $152 | $160 | $164 | $195 | $194 |
| Total Assets | $452 | $476 | $464 | $614 | $618 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 44 | 79 | 57 | 70 | 109 |
| Accrued Expenses | 9 | 11 | 10 | 26 | N/A |
| TOTAL | $68 | $104 | $69 | $102 | $111 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $68 | $104 | $69 | $102 | $111 |
| Shareholders' Equity | |||||
| Retained earnings | -4,000 | -4,008 | -3,975 | -3,891 | -3,871 |
| Other shareholders' equity | 192 | 188 | 177 | 212 | 186 |
| TOTAL | $384 | $372 | $395 | $513 | $507 |
| Total Liabilities And Equity | $452 | $476 | $464 | $614 | $618 |